As of March 1, 2006, a new, enhanced Accutane® pregnancy risk management program called iPLEDGE has replaced
the SMART® program. Prescribers and patients must register with iPLEDGE in order to prescribe or obtain
prescriptions for Accutane or its generic equivalents. For more information,
waiting for hand_moderation
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
CONTRAINDICATIONS AND WARNINGS
Accutane must not be used by female patients who are or may become pregnant.
There is an extremely high risk that severe birth defects will result if pregnancy
occurs while taking Accutane in any amount, even for short periods of time.
Potentially any fetus exposed
waiting for hand_moderation
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0
(marketed as Accutane) Capsule Information
IPLEDGE Update (10/2007) : FDA is providing an update about iPLEDGE, a risk management program to reduce the risk of fetal exposure to isotretinoin (a drug to treat severe recalcitrant nodular acne). FDA approved several changes to the program.
FDA ALERT
waiting for hand_moderation
Date Added: Feb 12, 2009 Hits: Rating: 0.00 Votes: 0